Phenotypes associated with this allele
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Usp11tm1Tac mutation
(0 available);
any
Usp11 mutation
(14 available)
|
|
|
mortality/aging
N |
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(TRAMP)8247Ng mutation
(1 available)
Usp11tm1Tac mutation
(0 available);
any
Usp11 mutation
(14 available)
|
|
|
neoplasm
|
• tumors progress to a highly penetrant invasive prostatic adenocarcinoma unlike in age-matched transgenic mice wild-type for Usp11
|
|
• significantly higher rate of high grade prostatic intraepithelial neoplasia compared to transgenic mice wild-type for Usp11
|
|
• at 20 weeks of age tumor masses show severe malignant progression unlike in age-matched transgenic mice wild-type for Usp11
• prostatic tumor nodules metastasize to lymph nodes at a higher rate compared to age-matched transgenic mice wild-type for Usp11
|
|
• tumor masses are larger at 20 weeks of age compared to transgenic mice wild-type for Usp11
|
endocrine/exocrine glands
|
• tumors progress to a highly penetrant invasive prostatic adenocarcinoma unlike in age-matched transgenic mice wild-type for Usp11
|
|
• significantly higher rate of high grade prostatic intraepithelial neoplasia compared to transgenic mice wild-type for Usp11
|
reproductive system
|
• tumors progress to a highly penetrant invasive prostatic adenocarcinoma unlike in age-matched transgenic mice wild-type for Usp11
|
|
• significantly higher rate of high grade prostatic intraepithelial neoplasia compared to transgenic mice wild-type for Usp11
|
Allelic Composition |
Usp11tm1Tac/Y
|
|
Genetic Background |
involves: 129 * C57BL/6 |
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Usp11tm1Tac mutation
(0 available);
any
Usp11 mutation
(14 available)
|
|
|
cellular
|
• in a wounding assay primary MEFs show more rapid wound closure compared to wild-type controls
• increase in the rates of glucose uptake, lactate production, and glutamine consumption in primary MEFs compared to wild-type controls
|
|
• primary MEFs show a higher rate of growth compared to wild-type controls
|
endocrine/exocrine glands
|
• enlarged lobes at 11 weeks of age
|
reproductive system
|
• enlarged lobes at 11 weeks of age
|